Ensysce Biosciences (ENSCW) Other Accumulated Expenses (2020 - 2025)

Ensysce Biosciences (ENSCW) has 6 years of Other Accumulated Expenses data on file, last reported at $993411.0 in Q4 2025.

• Other Accumulated Expenses for Q4 2025 came in at $993411.0, up 81.13% year-over-year; the trailing twelve-month figure through Dec 2025 was $993411.0 (up 81.13% YoY), and the FY2025 annual result was $993411.0, up 81.13% from the prior year.
• Other Accumulated Expenses slipped to $993411.0 in Q4 2025 per ENSCW's latest filing, from $1.5 million in the prior quarter.
• Over five years, Other Accumulated Expenses peaked at $3.7 million in Q3 2021 and troughed at $370186.0 in Q2 2024.
• A 5-year average of $1.4 million and a median of $993411.0 in 2025 frame the typical range for Other Accumulated Expenses.
• The sharpest annual moves came in 2021 and 2024: Other Accumulated Expenses surged 888.29% in 2021, then slumped 82.68% in 2024.
• A 5-year view of Other Accumulated Expenses shows it stood at $3.4 million in 2021, then slumped by 34.66% to $2.2 million in 2022, then sank by 75.65% to $542260.0 in 2023, then rose by 1.14% to $548458.0 in 2024, then soared by 81.13% to $993411.0 in 2025.
• Business Quant data shows ENSCW's Other Accumulated Expenses at $993411.0 in Q4 2025, $1.5 million in Q3 2025, and $1.0 million in Q2 2025.